Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00956956 | A Multiple Dose Study To Determine Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Healthy Adult Subjects | PHASE1 | COMPLETED | 36 | — | — | Sep 1, 2009 | Dec 1, 2009 | Jan 7, 2010 | 1 | Singapore |
| Arm | Type | Description |
|---|---|---|
| PF-04455242 treatment | EXPERIMENTAL | - |
| Placebo | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| PF-04455242 | DRUG | 3, 6, and 23 mg capsules administered orally Q6 hours for 7 days of dosing. |
| Placebo | DRUG | Placebo administered orally Q6 hours for 7 days of dosing. |
Inclusion Criteria: * Healthy male and/or female subjects without childbearing potential between the ages of 21 and 55 years, inclusive. (Healthy is defined as no clinically relevant abnormalities identified by a detailed medical history, full physical examination, including blood pressure and puls...